Can-Fite BioPharma Ltd. Quarterly Common Stock, Shares Authorized from Q4 2018 to Q4 2023

Taxonomy & unit
us-gaap: shares
Description
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Summary
Can-Fite BioPharma Ltd. quarterly Common Stock, Shares Authorized history and growth rate from Q4 2018 to Q4 2023.
  • Can-Fite BioPharma Ltd. Common Stock, Shares Authorized for the quarter ending December 31, 2023 was 5B shares, unchanged year-over-year.
Common Stock, Shares Authorized, Quarterly (shares)
Common Stock, Shares Authorized, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 5B 0 0% Dec 31, 2023 20-F 2024-03-28
Q2 2023 5B 0 0% Jun 30, 2023 6-K 2023-08-31
Q4 2022 5B 0 0% Dec 31, 2022 20-F 2024-03-28
Q2 2022 5B 0 0% Jun 30, 2022 6-K 2022-08-25
Q4 2021 5B +4B +400% Dec 31, 2021 20-F 2023-03-30
Q2 2021 5B +4.5B +900% Jun 30, 2021 6-K 2021-08-26
Q4 2020 1B +500M +100% Dec 31, 2020 20-F 2022-03-24
Q2 2020 500M Jun 30, 2020 6-K 2020-08-27
Q4 2019 500M 0 0% Dec 31, 2019 20-F 2021-03-25
Q4 2018 500M Dec 31, 2018 6-K 2020-06-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.